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ABSTRACT
Objectives Our aim was to explore junior doctors’
attitudes and awareness around concepts related to
medication review, in order to ﬁnd ways to change the
culture for reviewing, altering and stopping inappropriate
or unnecessary medicines. Having already demonstrated
the value of team working with senior doctors and
pharmacists and the use of a medication review tool, we
are now looking to engage ﬁrst year clinicians and
undergraduates in the process.
Method An online survey about medication review was
distributed among all 42 foundation year one (FY1)
doctors at the Chelsea and Westminster Hospital NHS
Foundation Trust in November 2014. Descriptive statistics
were used for analysis.
Results Twenty doctors completed the survey (48%).
Of those, 17 believed that it was the pharmacist’s duty
to review medicines; and 15 of 20 stated the general
practitioner (GP). Sixteen of 20 stated that they would
consult a senior doctor ﬁrst before stopping medication.
Eighteen of 20 considered the GP and consultant to be
responsible for alterations, rather than themselves.
Sixteen of 20 respondents were not aware of the
availability of a medication review tool. Seventeen of 20
felt that more support from senior staff would help them
become involved with medication review.
Conclusions Junior doctors report feeling
uncomfortable altering mediations without consulting a
senior ﬁrst. They appear to be building conﬁdence with
prescribing in their ﬁrst year but not about the
medication review process or questioning the drugs
already prescribed. Consideration should be given to
what we have termed a ‘bottom-up’ educational
approach to provide early experience of and change the
culture around medication review, to include the
education of undergraduate and foundation doctors and
pharmacists.
INTRODUCTION
The UK Department of Health quotes a deﬁnition
of medication review as ‘A structured, critical exam-
ination of a patient’s medicines with the objective
of reaching an agreement with the patient about
treatment, optimising the impact of medicines,
minimising the number of medication-related pro-
blems and reducing waste’.1 Medication review,
including ‘deprescribing’ inappropriate or unneces-
sary medicines should be part of routine prescrib-
ing practice in all healthcare settings; particularly in
older populations given that problematic prescrib-
ing is estimated to occur in more than one-third of
over 70 year olds.2 3 The setting for medication
review includes secondary care (hospitals), where
doctors in their ﬁrst year of practice (known in the
UK as ‘foundation year one’ or ‘FY1’) are involved
in prescribing and dosing adjustments particularly
for acutely unwell patients. These patients may
have come into the hospital without their regular
medicines or an up-to-date list, leading to delays or
unsafe treatment. Unreconciled medicines com-
promise optimum review of medicines in the acute
setting (V Marvin et al, unpublished data, April
2015). In addition, medication-related problems
may have contributed to the presenting complaint,
or an adverse drug reaction could be the cause of
hospitalisation.4
Urgency and complexity of overall care make
identifying potentially inappropriate medications as
part of a medication review a signiﬁcant challenge
in the acute setting. Locally, the medicines policy
for our hospital contains standards for good medi-
cines management including prescribing. Many
British hospitals follow the Royal Pharmaceutical
Society standards for hospital services where it is
stated that on admission, or at ﬁrst contact with the
patient, medicines should also be reviewed for clin-
ical appropriateness and to identify patients in need
of further pharmacy support. Moreover, the phar-
macy team should provide the leadership, systems
support and expertise that enable a multiprofes-
sional team to do this as part of the admission
process.5
However, reviewing and stopping medicines do
not appear to be part of the culture of routine prac-
tice and generally not part of the admitting
( junior) doctor’s process. There is evidence that at
the early stages of a medical career, doctors may
not possess sufﬁcient competence and conﬁdence
to perform a medication review,6 and may feel
uncomfortable stopping medicines that more senior
doctors have initiated; indicative perhaps of hier-
archical dominance. Research is needed to explore
the ability and attitudes of junior doctors in con-
tributing to medication review, as well as their
awareness of medication review tools that have
been developed to aid them in this process. This
will allow us to identify barriers to the contribution
of FY1 doctors to managing medicines in the acute
setting, where they are regular prescribers if not
‘deprescribers’.
The National Institute of Health Research
(NIHR) Collaboration for Leadership in Applied
Health Research and Care Northwest London
(CLAHRC NWL) is a programme hosted by the
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Chelsea & Westminster Hospital NHS Foundation Trust
(CWFT). Their remit is to translate research into practice, and
ﬁnd how to best embed the changes made. Early CLAHRC
NWL improvement projects led to interventions involving phar-
macists working closely with junior doctors to facilitate accurate,
reliable medicines reconciliation at admission to hospital and
through to discharge. Further work included adapting the ori-
ginal Screening Tool of Older Persons potentially inappropriate
Prescriptions (STOPP) medication review tool,7 through which
it was found that 1331/1368 older patients (97%) were pre-
scribed at least one medicine indicated as a potential problem.8
This tool was developed into the ‘STOPIT’ tool used at CWFT,
to provide structure and facilitate the medication review process
for all clinicians with particular effectiveness demonstrated in
the elderly rehabilitation setting.9
Using the action–effect method (a quality improvement
method)10 (see online supplementary appendix), a need for
research into the role of junior doctors in medication review
was identiﬁed as part of CLAHRC NWL’s overall medicines
optimisation themes. NIHR CLAHRC NWL brought together
stakeholders interested in medication review in the elderly acute
care setting and facilitated a session to develop a shared aim for
collaboration, the achievement of which would be contingent
on ﬁnding an effective, reliable and embedded process for
reviewing and optimising medicines within all settings. The
project team used the action–effect method to develop cause–
effect chains to inﬂuence these factors, highlighting a need to
develop and embed a culture where optimising medicines for an
individual patient is the norm. We postulated that junior doctors
require the development of skills, conﬁdence and awareness to
contribute to the medication review process. This article dis-
cusses the further analysis of the survey results, some of which
were presented at a recent conference.11
Objectives
1. To elicit junior doctors’ attitudes to and awareness of the
need to review medicines in elderly patients.
2. To explore factors that may hinder medication review and
deprescribing.
3. To use this information to formulate a ‘bottom-up’ approach
to educate foundation and undergraduate doctors and phar-
macists in preparation for their roles in medication review.
METHOD
Ethics approval was sought from CWFT Research and
Development and National Research Ethics Service (NRES) but
was deemed not required as this was a service evaluation.
Our study comprised an online questionnaire survey that
investigated the attitudes of all CWFT FY1 doctors to concepts
around medication review and their familiarity with medication
review tools. The survey was phrased to avoid confusion
between ‘medication review’ and ‘medicines reconciliation’. A
focus group of two senior CWFT/CLAHRC pharmacists, a con-
sultant geriatrician, two FY1 doctors and an undergraduate
pharmacy student used the action–effect diagram to identify
survey themes.
Thirteen questions were derived from the focus group
themes, and circulated among the group for further comments
before piloting in October 2014. The survey was designed in
the online survey tool SurveyMonkey; where a question offered
an ‘other’ response to tick, with a free text box provided to
allow for any additional comments.
The ﬁnal postpilot survey comprised 16 questions and was
distributed to all 42 FY1 doctors within CWFT between 27
October 2014 and 23 November 2014. An incentive was
offered in the form of a voucher drawn at random from partici-
pating doctors. Strategies for improving survey response rate
were developed iteratively using plan-do-study-act (PDSA)
cycles. This is an improvement science methodology facilitated
by CLAHRC NWL to plan, predict, record and adapt our meth-
odology through a series of methodical pilot studies.12
Descriptive statistics were used for frequency of responses
and where appropriate cross-tabulations were applied. Given the
sample size, no inferential statistics were applied, with a focus
given to qualitative aspects to highlight areas in which training
interventions can be made. The results for this are broken down
by theme: specialty of the FY1, medication review, medication
review tools, feelings around prescribing and stopping medica-
tion and what would help.
RESULTS
Between 28 October 2014 and 21 November 2014, 12 online
responses were received. Using PDSA methodology, the team
gathered at a CWFTweekly junior doctor training session on 21
November 2014 and distributed paper copies of the survey
which yielded a further eight responses. The survey was closed
on 23 November 2014, with a response rate of 20/42 FY1
doctors (48%). Eleven of 20 (55%) respondents were working
in medicine, six in surgery (30%) and three (15%) in acute
medicine.
Medication review
Table 1 states the self-reported frequency of medication review
undertaken by FY1 doctors on their elderly patients. ‘Other’
(free text) responses included (frequency in brackets): once per
admission (2), when the patient has a prolonged stay (1), if
asked by a consultant/pharmacy/need something new (1) and
every 2–3 days (1).
The opinions of FY1 doctors on who reviews and stops medi-
cation are shown in tables 2 and 3, respectively. Reviewing
elderly patient’s medication is mostly commonly thought to be
carried out by the pharmacist, followed by general practitioner
(GP), specialist registrar (SpR) and consultant. All three ‘other’
responses in table 2 stated the FY1 doctor.
The majority of participants chose GP and consultant for
being the professionals they believe are responsible for stopping
elderly patient’s medication. The SpR was the next most
popular option, followed by senior house ofﬁcer (SHO), FY1
and pharmacist.
Table 1 The frequency of medication review undertaken by
foundation year one (FY1) doctors on their elderly patients
Frequency Daily Every ward round Weekly Never Other
Responses 6 5 3 1 5
Table 2 Responses to ‘who reviews elderly patient’s medication?’
(multiple options permitted)
Professional Pharmacist GP SpR Consultant Other*
Responses 17 15 11 10 3
GP, general practitioner; SpR, specialist registrar.
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Within their current specialty, most FY1 doctors reported
stopping medications weekly (11), with no respondents report-
ing ‘never’. Outside their specialty; however, FY1s reported
either never stopping medicines (7) or only do so monthly (6).
No FY1s reported stopping medications daily (ﬁgure 1).
Medication review tools
Sixteen out of 20 FY1 doctors reported having never heard of a
medication review tool. Three of the remaining four doctors
stated having heard of the STOPIT tool (see the Introduction)
and one had heard of STOPP/START.13 When questioned if the
FY1s had ever used the selected tool in clinical practice, only
one respondent stated yes.
Feelings around prescribing and stopping medication
Sixteen out of 20 FY1 doctors reported feeling comfortable pre-
scribing within their current specialty. The same number of
doctors also stated feeling uncomfortable stopping or starting a
medication without speaking to a senior ﬁrst.
No respondent reported feeling ‘very uncomfortable’ pre-
scribing within their specialty; however, 10 FY1 doctors
reported feeling uncomfortable with prescribing medication
outside of their current specialty.
Eighteen out of 20 FY1s stated having questioned the suitabil-
ity of a medicine for an elderly patient; the others reporting that
they had not done this. After questioning the medication, the
FY1s working in medicine (following analysis by speciality) were
more likely to speak to their SHO/SpR/consultant (ﬁgure 2).
Seventeen out of 20 respondents would approach a pharma-
cist if they did not recognise a medication prescribed for their
elderly patient. This was followed by registrars (12 responses).
‘Other’ responses included (frequency in brackets): British
National Formulary (4) and Foundation Year Two doctors (2)
(ﬁgure 3).
What would help with conﬁdence in medication review?
When asked what would help FY1 doctors become more conﬁ-
dent in making suggestions to review/stop medicines, 17/20 par-
ticipants chose ‘support from senior doctors’, followed by 10/20
selecting ‘my team being more open to medication review’.
Nine out of 20 equally stated that support from pharmacists
and a medication review tool would be of help. Finally, 7/20
reported that more teaching on the subject in the medical
school syllabus would help improve their conﬁdence in stopping
and reviewing medicines.
DISCUSSION
Our FY1 survey is an early contribution to the investigation of
FY1 doctors’ views about medication review and awareness of
medication review tools. Although the sample size was small,
with a possibility of responder-selection bias given the 48%
response rate, the results were as the project team expected, sug-
gesting that if FY1s do undertake medication review, it is likely
to be speciality speciﬁc and any further review is likely to
require support from seniors. If FY1s have questions about
whether to review or stop medicines, their seniors would be
consulted, rather than their pharmacists, to whom they would
address speciﬁc questions about unfamiliar medicines.
Conﬁdence and competence of FY1s in undertaking medication
review may be a reason for not undertaking full reviews, and
the majority of FY1s were not aware of medication review tools
‘STOPIT’ and ‘STOPP’.7 13
There may be a number of reasons why FY1 doctors may not
perform routine, complete medication reviews. It could be that
they lack familiarity with the concept or deﬁnition of medica-
tion review,1 or conﬁdence in using medication review tools. We
have also discussed locally the expectations around whether a
medication review is required. For example, local focus groups
suggested that indications for medicines are frequently not
known to the admitting team, medication lists may not be up to
date, and surgical teams may be reluctant to change medica-
tions.9 These factors may give the message to junior doctors
that a medication review is not needed or is impractical.
Moreover, junior doctors may lack the required competence in
Table 3 Responses to ‘who stops elderly patient’s medication?’
(multiple options permitted)
Professional Consultant GP SpR SHO FY1 Pharmacist
Responses 18 18 15 14 9 8
FY1, foundation year one; GP, general practitioner; SHO, senior house officer; SpR,
specialist registrar.
Figure 1 Responses to ‘with what
frequency do you stop medicines?’
within and outside the specialty to
which currently attached.
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evaluating medication across a range of multimorbidities in
older people. It may also be that senior staff, when undertaking
medication review, do not do it in the presence of the junior
doctors and/or do not share their methodology or rationale,
making the process of structured medication review invisible to
junior doctors and preventing learning. These factors could con-
spire so as to reduce opportunities to gain experience, and with
past events guiding future behaviours.14 This may impact the
capability to perform such review tasks. In addition, FY1s may
believe that medication review is the responsibility of more
senior staff and thus they do not need to be involved, or have a
reluctance to review and optimise (including appropriate depre-
scribing) what senior doctors, including GPs, have previously
prescribed. In this respect, we consider that hierarchical domin-
ance is a theme worthy of further exploration. The aviation
industry suffered a number of catastrophic events that led to
changes whereby hierarchy is maintained; but a less authoritar-
ian stance is sought to make optimum use of all available
resources, including people, to promote safety and efﬁciency.15
This provides a supportive learning opportunity within a multi-
disciplinary team to gain experience. This approach, through a
number of iterations, has been used within the healthcare set-
tings.16–18 As we apply these principles, we propose that a
‘bottom-up’ approach to medication review may begin the
change of culture and acquisition of experience that engages
doctors and pharmacists at the undergraduate and foundation
levels in the medication review process. Seven out of 20 of our
FY1 respondents supported the introduction of relevant under-
graduate education.
Study limitations and future work
Although our survey is not validated and this study is explora-
tory in nature, the purpose was to begin to elucidate our FY1
doctors’ attitudes to and awareness around speciﬁc questions
relating to the concept of medication review. For example, one
question was ‘Have you questioned in your mind whether a
Figure 2 For those answering ‘yes’
(18/20) to ‘have you questioned in
your mind whether a medicine for one
of your elderly patients is necessary?’
This chart shows the responses to
‘what did you do about it?’ SHO,
senior house ofﬁcer; SpR, specialist
registrar.
Figure 3 Responses to ‘who would
you ask if you see a medication
prescribed for your elderly patient that
you don’t recognise?’ (multiple options
permitted).
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medicine for one of your elderly patients is necessary?’ Little lit-
erature, if any, elucidates the views of junior doctors around
concepts related to medication review. This FY1 survey begins
to explore this and we plan to repeat the medication review
survey for all FY1 doctors in London, given the generalisability
of our work and the need to ensure that non-responder and
social desirability bias are properly evaluated.
The survey results are useful as we consider the education of
pharmacists and doctors at CWFT. Moreover, through discus-
sion of the ﬁndings of our projects within NIHR CLAHRC
NWL and with our junior doctors, we are in 2015 seeking to
launch a ‘bottom-up’ approach to engaging doctors and phar-
macists in the medication review process in all settings, includ-
ing acute care. We hope to inﬂuence undergraduate and
foundation education for doctors and pharmacists in London
and possibly beyond, a concept that has recently been supported
outside Europe.19 Our approach is ﬁrmly based on the principle
that appropriate medication review must be based on adequate
medicines reconciliation (V Marvin et al, unpublished data,
April 2015), and our local work supports the notion that inter-
disciplinary medication review is an ideal way to review medica-
tion.9 We also believe that the use of medication review tools
can equip junior doctors and pharmacists to participate in the
review process by prompting senior clinicians in the acute
setting and after discharge from hospital. This may support GPs
in managing their primary care patients with clear, concise and
complete information about medication review undertaken
during a hospital admission. We are acutely aware of the need
to ensure and teach novice practitioners not to deprescribe
indiscriminately, but prompt their seniors for support, having
identiﬁed possible medicines to review. Educating undergraduate
and foundation doctors and pharmacists will also prepare them
for their responsibilities as seniors around appropriate prescrib-
ing and deprescribing, not least through gaining experience. To
this end, we have begun to inﬂuence the undergraduate curricu-
lum in one pharmacy school by running ﬁnal year medication
review case studies, and are suggesting medication
review-related learning outcomes for the London-wide and
national foundation curricula for pharmacists. Our next steps
are to emulate this activity for medical schools and foundation
doctor training.
CONCLUSION
We encourage our European colleagues to explore the ability of
and any barriers to junior doctors and pharmacists to contribute
to the medication review process in the acute setting, and to
ensure that they understand the imperative of adequate medi-
cines reconciliation, where appropriate for their health system,
before undertaking a medication review.
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